Prevalence of Mycoplasma spp. in the Respiratory Tract of Healthy North American Bison (Bison bison) and Comparison with Serum Antibody Status.

Mycoplasma bovis is a primary cause of respiratory and reproductive diseases in North American bison (Bison bison), with significant morbidity and mortality. The epidemiology of M. bovis in bison is poorly understood, hindering efforts to develop effective control measures. Our study considered whether healthy bison might be carriers of M. bovis, potentially serving as unrecognized sources of exposure. We used culture and PCR to identify mycoplasmas in the nasal cavity or tonsil of 499 healthy bison from 13 herds and two abattoirs in the US and Canada. Mycobacterium bovis was detected in 15 bison (3.0%) representing two herds in the US and one in Canada, while M. bovirhinis, M. bovoculi, M. arginini, or M. dispar was identified from an additional 155 bison (31.1%). Mycoplasma bovirhinis was identified most frequently, in 142 bison (28.5%) representing at least 10 herds. Of the 381 bison for which serum was available, only 6/13 positive for M. bovis (46.2%) tested positively with an M. bovis ELISA, as did 19/368 negative for M. bovis (5.2%). Our data reveal that M. bovis can be carried in the upper respiratory tract of healthy bison with no prior history or clinical signs of mycoplasmosis and that a large proportion of carriers may not produce detectable antibodies. Whether carriage of other mycoplasmas can trigger cross-reactive antibodies that may confound M. bovis serology requires further study.

Traceback of the Psoroptes outbreak in British Columbian bighorn sheep (Ovis Canadensis).

Psoroptes are a non-burrowing, ectoparasitic, mange-causing mite that has been documented in American bighorn sheep populations throughout the 19th and 20th centuries; however, it was not seen on Canadian bighorn sheep until 2006. The aim of this study was to determine the potential source of the Psoroptes outbreak in Canadian bighorn sheep. Morphological and molecular analyses were used to compare mites recovered from outbreak-associated bighorn sheep, pet rabbits in Canada, and on historically infested bighorn sheep in the USA. The results revealed that Psoroptes acquired from the Canadian and outbreak-associated American bighorn sheep were morphologically more similar to those collected from rabbits than mites on historically infested bighorn sheep. Outer opisthosomal setae lengths measured an average of 81.7 µm (±7.7 µm) in outbreak associated bighorn mites, 88.9 µm (±12.0 µm) in rabbit mites and 151.2 µm (±16.6 µm) in historically infested bighorn mites. The opisthosomal lobe morphology of bighorn mites in the outbreak herds was also more similar to that of rabbit mites, previously described as P. cuniculi, than historically infested bighorn mites, which match previous descriptions of P. ovis. This finding was supported by DNA sequence data of the mitochondrial cytochrome B gene. This is the first report of Psoroptes of the rabbit ecotype on bighorn sheep. The morphological and molecular data therefore support the hypothesis that the source of Psoroptes outbreak in Canadian bighorn sheep represented a disease spillover event from rabbits rather than transmission from infested American bighorn sheep populations.

Serological evidence for historical and present-day exposure of North American bison to Mycoplasma bovis.

BACKGROUND: Mycoplasma bovis causes mastitis, otitis, pneumonia and arthritis in cattle and is a major contributor to bovine respiratory disease complex. Around the year 2000, it emerged as a significant threat to the health of North American bison. Whether healthy bison are carriers of M. bovis and when they were first exposed is not known. To investigate these questions we used a commercially available ELISA that detects antibodies to M. bovis to test 3295 sera collected from 1984 through 2019 from bison in the United States and Canada. RESULTS: We identified moderately to strongly seropositive bison from as long ago as the late 1980s. Average seroprevalence over the past 36 years is similar in the United States and Canada, but country-specific differences are evident when data are sorted by the era of collection. Seroprevalence in the United States during the pre-disease era (1999 and prior) was significantly higher than in Canada, but was significantly lower than in Canada during the years 2000-2019. Considering individual countries, seroprevalence in the United States since the year 2000 dropped significantly as compared to the years 1985-1999. In Canada the trend is reversed, with seroprevalence increasing significantly since the year 2000. ELISA scores for sera collected from free-ranging bison do not differ significantly from scores for sera from more intensively managed animals, regardless of the era in which they were collected. However, seroprevalence among intensively raised Canadian bison has nearly doubled since the year 2000 and average ELISA scores rose significantly. CONCLUSIONS: Our data provide the first evidence that North American bison were exposed to M. bovis many years prior to the emergence of M. bovis-related disease. Patterns of exposure inferred from these results differ in the United States and Canada, depending on the era under consideration. Our data further suggest that M. bovis may colonize healthy bison at a level sufficient to trigger antibody responses but without causing overt disease. These findings provide novel insights as to the history of M. bovis in bison and will be of value in formulating strategies to minimize the impact of mycoplasmosis on bison health and production.

Evaluation of intramuscular sodium nitroprusside injection to improve oxygenation in white-tailed deer (Odocoileus virginianus) anesthetized with medetomidine-alfaxalone-azaperone.

OBJECTIVE: In ungulates, α2-adrenergic agonists can decrease oxygenation possibly through alteration of pulmonary perfusion. Sodium nitroprusside can decrease pulmonary vascular resistance (PVR) and increase cardiac output (Q˙t) through vasodilation. The objective was to determine if sodium nitroprusside would improve pulmonary perfusion and attenuate the increased alveolar-arterial (a-a) gradient resulting from medetomidine-azaperone-alfaxalone (MAA) administration. STUDY DESIGN: Prospective, randomized, crossover study with a 2 week rest period. ANIMALS: A group of eight adult female captive white-tailed deer (Odocoileus virginianus). METHODS: Deer were administered MAA intramuscularly (IM), and auricular artery and pulmonary artery balloon catheters were placed. Deer spontaneously breathed air. Saline or sodium nitroprusside (0.07 mg kg-1) were administered IM 40 minutes after MAA injection. Heart rate (HR), mean arterial pressure (MAP), mean pulmonary arterial pressure (MPAP), pulmonary artery occlusion pressure (PAOP), right atrial pressure (RAP), Q˙t, arterial pH, PaCO2 and PaO2 were obtained immediately before nitroprusside injection (baseline) and 5, 10 and 15 minutes afterwards. Mixed venous blood samples were obtained at baseline and at 5 minutes. Systemic vascular resistance (SVR), PVR, intrapulmonary shunt fraction (Q˙s/Q˙t), a-a gradient, oxygen delivery (D˙O2) and oxygen extraction ratio (O2ER) were calculated. Statistical analysis was performed with repeated measures analysis of variance with correction factors. A p value < 0.05 was considered significant. RESULTS: With nitroprusside, MAP, MPAP, PAOP, RAP, SVR and O2ER significantly decreased and HR, Q˙t and D˙O2 increased compared with baseline and between treatments. There was a significant decrease in PVR and a-a gradient and increase in PaO2 compared with baseline and saline treatment. Changes were not sustained. CONCLUSIONS AND CLINICAL RELEVANCE: Nitroprusside temporarily changed hemodynamic variables, increased PaO2 and decreased a-a gradient. Nitroprusside possibly led to better pulmonary perfusion of ventilated alveoli. However, IM nitroprusside at this dose is not recommended because of severe systemic hypotension and short action.

Complete Genome Sequences of 16 Mycoplasma bovis Isolates from Canadian Bison and Cattle.

Here, we report the complete genome sequences of 12 Mycoplasma bovis isolates cultured from Canadian bison and 4 cultured from Canadian cattle. The sequences are of value for understanding the phylogenetic relationship between cattle and bison isolates and will aid in elucidating the genetic basis for virulence and host specificity.

Pharmacokinetics of imidocarb dipropionate in white-tailed deer (Odocoileus virginianus) after single intramuscular administration.

This study was designed to investigate the pharmacokinetics of imidocarb, a carbanilide derivative, in white-tailed deer (Odocoileus virginianus). The pharmacokinetic properties of a single intramuscular (IM) dose of imidocarb were determined in 10 deer. A single IM injection of 3.0 mg/kg imidocarb dipropionate was administered, and blood samples were collected prior to, and up to 48 hr after imidocarb administration. Plasma imidocarb concentrations were determined by high-performance liquid chromatography with ultraviolet detection. The disposition of plasma imidocarb was best characterized by a two-compartment open model. The mean ± SE maximal imidocarb concentration in deer was 880.78 ± 81.12 ng/ml at 38.63 ± 5.30 min postinjection. The distribution phase had a half-life (t1/2α ) of 25.90 ± 10.21 min, and plasma imidocarb concentration declined with a terminal elimination half-life (t1/2ß ) of 464.06 ± 104.08 min (7.73 ± 1.73 hr). Apparent volume of distribution based on the terminal phase (VZ /F) was 9.20 ± 2.70 L/kg, and apparent total body clearance (Cl/F) was 15.97 ± 1.28 ml min-1  kg-1 .

Comparison of multilocus sequence types found among North American isolates of Mycoplasma bovis from cattle, bison, and deer, 2007-2017.

A prior multilocus sequence typing (MLST) study reported that Mycoplasma bovis isolates from North American bison possess sequence types (STs) different from those found among cattle. The 42 bison isolates evaluated were obtained in 2007 or later, whereas only 19 of 94 (~20%) of the available cattle isolates, with only 1 from North America, were from that same time. We compared STs of additional, contemporary, North American cattle isolates with those from bison, as well as isolates from 2 North American deer, all originating during the same timeframe, to more definitively assess potential strain-related host specificity and expand our understanding of the genetic diversity of M. bovis. From 307 isolates obtained between 2007 and 2017 (209 from cattle, 96 from bison, 2 from deer), we identified 49 STs, with 39 found exclusively in cattle and 5 exclusively in bison. Four STs were shared between bison and cattle isolates; one ST was found in cattle and in a deer. There was no clear association between ST and the health status of the animal of origin. An MLST-based phylogeny including 41 novel STs identified in our study reveals that STs found in bison fall within several divergent lineages that include STs found exclusively in cattle.

Observations of mortality in farmed bison in the Canadian prairies: 2103 - 2016.

The present study is a continuation of a previous mortality study on Saskatchewan bison farms with special emphasis on Malignant Catarrhal Fever. The updated objective of the study was to estimate the most common causes of mortality in farmed bison herds in Western Canada. Results were compared to the previous Saskatchewan study to assess the similarities and differences in the etiology associated with farmed bison deaths across the Prairie Provinces of Canada. The most common cause of death was respiratory disease associated with Mycoplasma bovis, although this was restricted to Alberta and Saskatchewan farm locations. This was in contrast to the previous Saskatchewan based study which did not identify any deaths involving this pathogen. An updated overall assessment of the risks of Malignant Catarrhal Fever in farmed bison at various proximities to sheep operations further confirmed the low risk of occurrence on farms within a 1 km boundary fence distance.

High species diversity of trichostrongyle parasite communities within and between Western Canadian commercial and conservation bison herds revealed by nemabiome metabarcoding.

BACKGROUND: Many trichostrongylid nematode species are reported to infect bison, some of which are major causes of disase and production loss in North American bison herds. However, there is little information on the species distribution and relative abundance of these parasites in either commercial or conservation herds. This is largely because trichostrongylid nematode species cannot be distinguished by visual microscopic examination of eggs present in feces. Consequently, we have applied ITS2 rDNA nemabiome metabarcoding to describe the trichostrongyle parasite species diversity in 58 bison production groups derived from 38 commercial North American plains bison (Bison bison bison) herds from across western Canada, and two bison conservation herds located in Elk Island National Park (EINP) [plains bison and wood bison (Bison bison athabascae)] and one in Grasslands National Park (GNP) (plains bison). RESULTS: We report much higher infection intensities and parasite species diversity in commercial bison herds than previously reported in beef cattle herds grazing similar latitudes. Predominant trichostrongyle parasite species in western Canadian commercial bison herds are those commonly associated with Canadian cattle, with Ostertagia ostertagi being the most abundant followed by Cooperia oncophora. Combined with high fecal egg counts in many herds, this is consistent with significant clinical and production-limiting gastrointestinal parasitism in western Canadian bison herds. However, Haemonchus placei was the most abundant species in five of the production groups. This is both surprising and important, as this highly pathogenic blood-feeding parasite has not been reported at such abundance, in any livestock species, at such northerly latitudes. The presence of Trichostrongylus axei as the most abundant parasite in four herds is also unusual, relative to cattle. There were striking differences in parasite communities between the EINP and commercial bison herds. Most notably, Orloffia bisonis was the predominant species in the wood bison herd despite being found at only low levels in all other herds surveyed. CONCLUSIONS: This study represents the most comprehensive description of parasite communities in North American bison to date and illustrates the power of deep amplicon sequencing as a tool to study species diversity in gastrointestinal nematode communities.

Induction of PrPSc-specific systemic and mucosal immune responses in white-tailed deer with an oral vaccine for chronic wasting disease.

The ongoing epidemic of chronic wasting disease (CWD) within cervid populations indicates the need for novel approaches for disease management. A vaccine that either reduces susceptibility to infection or reduces shedding of prions by infected animals, or a combination of both, could be of benefit for disease control. The development of such a vaccine is challenged by the unique nature of prion diseases and the requirement for formulation and delivery in an oral format for application in wildlife settings. To address the unique nature of prions, our group targets epitopes, termed disease specific epitopes (DSEs), whose exposure for antibody binding depends on disease-associated misfolding of PrPC into PrPSc. Here, a DSE corresponding to the rigid loop (RL) region, which was immunogenic following parenteral vaccination, was translated into an oral vaccine. This vaccine consists of a replication-incompetent human adenovirus expressing a truncated rabies glycoprotein G recombinant fusion with the RL epitope (hAd5:tgG-RL). Oral immunization of white-tailed deer with hAd5:tgG-RL induced PrPSc-specific systemic and mucosal antibody responses with an encouraging safety profile in terms of no adverse health effects nor prolonged vector shedding. By building upon proven strategies of formulation for wildlife vaccines, these efforts generate a particular PrPSc-specific oral vaccine for CWD as well as providing a versatile platform, in terms of carrier protein and biological vector, for generation of other oral, peptide-based CWD vaccines.

A serologic survey of Mycoplasma spp. in farmed bison ( Bison bison) herds in western Canada.

Mycoplasma bovis is emerging as an important pathogen of farmed bison in North America and is associated with high morbidity and mortality in affected herds. We developed an in-house ELISA to detect antibodies against Mycoplasma spp. in bison sera. The aims of the study were to estimate the seroprevalence against Mycoplasma spp. in bison herds with or without past history of M. bovis-associated disease, and to determine potential risk factors for seropositivity to Mycoplasma spp. in farmed bison in western Canada. A total of 858 serum samples were collected from bison >1 y of age from 19 bison herds. The individual and herd-level seroprevalence of Mycoplasma spp. was 12% and 79%, respectively. The proportion of seropositive animals was 0-41% and 0-9% for herds with or without a history of M. bovis-associated disease, respectively. Mycoplasma spp. appear to be widespread in bison in Manitoba, Saskatchewan, and Alberta. Eight of 11 herds with no history of M. bovis-associated disease were seropositive for Mycoplasma spp., which suggests that bison can be subclinically infected with Mycoplasma spp., or that infection may be underdiagnosed. Although not specific to M. bovis, the in-house ELISA developed to detect antibodies against Mycoplasma spp. may prove to be a valuable herd-level screening tool, providing insight needed for the development of appropriate prevention and control measures for Mycoplasma-related disease in bison herds.

Effect of extending FSH treatment on superovulation and embryo production in wood bison (Bison bison athabascae).

The effect of extending the length of the FSH treatment protocol on superovulatory response and embryo production was investigated in wood bison during the anovulatory and ovulatory seasons. In Experiment 1 (anovulatory season), follicular wave emergence was synchronized by follicular ablation (Day -1) and bison were assigned randomly to two groups (n = 14/group) and given 200 mg FSH on Day 0 and Day 2 (non-extended group), or 133 mg FSH on Days 0, 2, and 4 (extended group). Human chorionic gonadotropin (hCG; 3000 IU) was given on Day 5 and Day 6 in the non-extended and extended groups, respectively, and bison were inseminated 12 and 24 h later. Ova/embryos were collected 8 days after hCG treatment. In Experiment 2 (ovulatory season), bison were synchronized and superstimulated as in Experiment 1 (n = 12/group), but prostaglandin was given to control CL development. Data were compared by t-test and Chi-square test. In Experiment 1, no differences in ovarian response or embryo production between groups were detected. In Experiment 2, there was no difference in the ovarian response between groups, however, a greater number of ova/embryos (4.3 ± 0.8 vs. 2.3 ± 0.4; P ≤ 0.05) and freezable embryos (2.5 ± 0.6 vs. 1.2 ± 0.4; P ≤ 0.05) were obtained in the extended group. The number of freezable embryos was greater during the ovulatory vs anovulatory season (1.8 ± 0.4 vs. 0.3 ± 0.2; P ≤ 0.05). In conclusion, extending the FSH treatment in wood bison did not improve the superovulatory response during the anovulatory season, but resulted in twice as many freezable embryos during the ovulatory season. The number of freezable embryos collected during the anovulatory season was <20% that of the ovulatory season.

Effects of eCG and progesterone on superovulation and embryo production in wood bison (Bison bison athabascae).

Experiments were done to determine if inclusion of eCG and progesterone in the superstimulation protocol will increase the ovarian response and embryo production in wood bison, and to provide preliminary information regarding the effect of season. In Experiment 1 (anovulatory season), bison (n=26) were synchronized by follicular ablation (Day -1) and given FSH on Days 0 and 2, and assigned to 3 groups: Progesterone (Days 0-4), eCG (Day 3), or progesterone+eCG. On Day 5, bison were given hCG and inseminated 12 and 24h later. Ova/embryos were collected 8days after hCG. In Experiment 2 (ovulatory season), bison (n=24) were synchronized and assigned randomly to two groups in which superstimulation was induced with FSH, either with or without eCG, as in Experiment 1. No differences among groups were found in ovarian response or embryo production in either experiment. The follicular count at wave emergence was positively correlated with the number of large follicles at the end of superstimulation in all groups. A significantly greater number of follicles present at wave emergence in the anovulatory vs. ovulatory season was associated with a greater number of CL at the time of embryo collection, but only half the number of freezable embryos. In conclusion, the number of transferable embryos collected (1-2/bison) was higher than in any previous report, but was not attributable to the inclusion of eCG or progesterone in the superovulatory protocol. The apparent effect of season on oocyte competence, and not superovulatory response, is worthy of further investigation.

Septicemic pasteurellosis in farmed elk (Cervus canadensis) in Alberta.

Septicemic pasteurellosis is a bacterial disease of domestic and wild animals including bison, elk, and pronghorn antelope caused by Pasteurella multocida. Here we report 2 cases of septicemic pasteurellosis in farmed elk. Pasteurella multocida serogroup B was isolated from multiple tissues in both animals. Gene sequencing (16S ribosomal RNA) and BLAST query confirmed that the sequence is 99% to 100% homologous to the P. multocida sequences in the database.

Pasteurellose septicémique chez des wapitis d'élevage(Cervus canadensis)en Alberta. La pasteurellose septicémique est une maladie bactérienne des animaux domestiques et sauvages, dont le bison, le wapiti et l'antilocarpe, qui est causée par Pasteurella multocida. Dans le présent article, nous présentons un rapport sur 2 cas de pasteurellose septicémique chez les wapitis d'élevage. Le sérogroupe B de Pasteurella multocida a été isolé dans des plusieurs tissus des deux animaux. Le séquençage des gènes (ARN ribosomique16S) et une recherche BLAST a confirmé que la séquence est de 99 % à 100 % homologue aux séquences de P. multocida dans la base de données.(Traduit par Isabelle Vallières).

A single laboratory-validated LC-MS method for the analysis of tulathromycin residues in bison and deer sera and selected tissues of white-tailed deer.

The performance characteristics of a newly developed liquid chromatography-mass spectrometry (LC-MS) method were validated and demonstrated to be fit for purpose in a pharmacokinetic and tissue depletion study of white-tailed deer and bison. Tulathromycin was extracted from bison and deer sera with acetonitrile or trifluoroacetic acid and K2 HPO4 (pH 6.8) buffer solution and cleaned up on a conditioned Bond-Elut cartridge. Tulathromycin, retained on the cartridge; it was eluted with methanol containing 2% formic acid, dried, re-constituted in methanol/1% formic acid, and analyzed by LC-MS. The limit of quantification (LOQ) of the method was 0.6 ng/mL in serum and 0.6 ng/g in tissue with RSDs ≤ 10% and accurate over the linear calibration range of 0.8-100 ng/mL for bison serum, 0.6-50 ng/mL for deer serum, 100-2500 ng/g for deer muscle tissue, and 500-5000 ng/g for deer lung tissue, all with coefficients of determination, r(2) ≥0.99. The validated method was used to quantify the concentration of tulathromycin residues in serum of bison and deer and selected tissue (lung and muscle tissue) samples obtained from 10 healthy, white-tailed deer that were administered the therapeutic dose approved for cattle (i.e., a single 2.5 mg/kg subcutaneous injection of tulathromycin in the neck). The deer were included in a tulathromycin drug depletion study. © 2016 Her Majesty the Queen in Right of Canada. Drug Testing and Analysis © 2016 John Wiley & Sons, Ltd.

Risk factors for Mycoplasma bovis-associated disease in farmed bison (Bison bison) herds in western Canada: A case-control study.

North American bison producers have been attempting to control and prevent Mycoplasma bovis-associated disease without the benefit of bison-specific knowledge. The objective of this study was to determine the clinical presentation of disease associated with M. bovis infection in western Canadian farmed bison, and to identify herd-level risk factors for M. bovis-associated disease. Bison producers (n=49) from western Canada (Manitoba, Saskatchewan, Alberta, and British Columbia) were selected for a 1:2 case-control study. Data were collected by an in-person interview using a questionnaire regarding clinical presentations of outbreaks and herd-level management factors. Risk factors associated with M. bovis outbreaks were identified using multivariable logistic regression analysis. All 17 case herds had a laboratory-confirmed diagnosis of M. bovis infection within the last 5 years. In 11 (65%) of the 17 case herds, disease associated with M. bovis infection recurred in subsequent years. Overall, 88% of case herds had recently introduced bison that later developed clinical signs associated with M. bovis infection. Within a bison operation, a median of 8% (Inter Quartile Range [IQR]: 3-11%) developed clinical signs: lameness, reluctance to move, swollen joints, difficulty breathing, coughing, sluggishness, and loss of body condition. Also, calving percentage the year after the first M. bovis outbreak was lower than calving percentage the year before the outbreak. Herd-level mortality risk during the first M. bovis outbreak in case herds ranged from 0.5 to 50% (median 5%, IQR: 3-10%) and the median case fatality risk was 100%. Case herds were more likely than control herds to have a feedlot unit (OR=7), to receive regular visits from rental trailers or trailers from other farms (OR=15), to annually vaccinate bison (OR=7), and to lose at least one bison due to fatal respiratory disease in the previous year (OR=9). These findings will aid development of evidence-based recommendations for management to prevent and control Mycoplasma bovis in farmed bison in Western Canada.

EFFICACY AND SAFETY OF A MEDETOMIDINE-AZAPERONE-ALFAXALONE COMBINATION IN CAPTIVE WHITE-TAILED DEER (ODOCOILEUS VIRGINIANUS).

Alfaxalone is a neurosteroid that interacts with gamma-aminobutyric type A receptors to produce central nervous system depression and muscle relaxation. The effects of alfaxalone vary from sedation to general anesthesia. Alfaxalone is synergistic with other tranquilizers and sedatives and therefore has the potential to improve existing alpha-2 adrenergic agonist-based combinations used for wildlife immobilization. The objective of this study was to determine the efficacy and cardiopulmonary effects of a medetomidine-azaperone-alfaxalone (MAA) combination in captive white-tailed deer (Odocoileus virginianus). Eight captive white-tailed deer were restrained in a drop-floor chute; hand injected i.m. with 0.15 mg/kg medetomidine, 0.2 mg/kg azaperone, and 0.5 mg/kg alfaxalone; and released into a small enclosure for observation. The deer were maintained in lateral recumbency for a total time from postinjection (PI) of the drug of 60 min. At 60 min PI, atipamezole was administered i.m. at five times the medetomidine dose. Heart rate, respiratory rate, rectal temperature, and direct systolic, mean, and diastolic arterial blood pressures were recorded every 5 min. Arterial blood samples were taken every 15 min for blood gas analysis. Level of sedation and quality of recovery were scored. Statistical analysis was performed using analysis of variance and descriptive statistics with a significance level of P < 0.05. Induction (time to lateral recumbency, 7.1 ± 2.4 min (mean ± SD) and recovery times (time to standing, 9.1 ± 3.1 min) were comparable to currently used medetomidine-based combinations in white-tailed deer. Major cardiopulmonary effects observed (values reported are 15 min PI of immobilizing drugs) were hypoxemia (PaO2, 54 ± 9 mm Hg), hypoventilation (PaCO2, 55 ± 3 mm Hg), and mixed acid-base disturbances (pH, 7.22 ± 0.04). No adverse effects were observed after recovery from anesthesia. MAA produced a satisfactory level of deep sedation for safe handling and minor procedures in captive white-tailed deer.

An observational study of mortality on bison farms in Saskatchewan with special emphasis on malignant catarrhal fever.

In December 2011, the Malignant Catarrhal Fever (MCF) Task Force in Saskatchewan recommended that research be conducted on the relationship between the proximity of bison and sheep under typical commercial production settings and bison deaths due to MCF. The objective of this study was to evaluate all causes of death in bison herds and compare the incidence of MCF in herds at varying distances of exposure from sheep operations. Necropsies were completed on 76 of 133 bison reported to have died during the 18-month study period. A total of 7 MCF deaths was reported from 2 large herds within 1.0 km of sheep operations. Although there was a greater risk of MCF deaths in bison herds within 1.0 km of sheep operations than in herds more than 1.0 km away, the overall incidence of MCF deaths within the study period was very low. Most deaths were attributed to non-infectious causes, including copper deficiency.

Étude observationnelle de la mortalité dans des fermes de bisons en Saskatchewan, avec une emphase particulière sur la fièvre catarrhale maligne des bovins. En décembre 2011, le groupe de travail de la Saskatchewan sur la fièvre catarrhale maligne des bovins (FCM) a recommandé la réalisation de travaux de recherche pour étudier le lien entre la proximité des bisons et des moutons dans des milieux de production commerciaux typiques et la mortalité des bisons attribuable à la FCM. La recherche avait pour but d'évaluer toutes les causes de mortalité dans les troupeaux de bisons, puis de comparer l'incidence de la FCM dans les troupeaux à diverses distances d'exposition des exploitations d'élevage de moutons. Des nécropsies ont été réalisées sur 76 des 133 bisons dont la mort a été signalée durant la période d'étude de 18 mois. Un total de sept morts causées par la FCM a été signalé dans deux grands troupeaux situés à une distance de moins de 1 km. Le risque de mortalité pour cause de FCM était supérieur dans les troupeaux de bisons situés à moins de 1 km des exploitations de moutons que dans les troupeaux situés à une distance de plus de 1 km. Cependant, l'incidence totale de mortalité causée par la FCM était très faible. La plupart des mortalités étaient attribuables à des causes non infectieuses, y compris une carence en cuivre.(Traduit par Isabelle Vallières).

A survey to detect Toxocara vitulorum and other gastrointestinal parasites in bison (Bison bison) herds from Manitoba and Saskatchewan.

An egg count survey using environmental fecal samples obtained in spring or early summer was conducted to estimate the apparent prevalence of Toxocara vitulorum in unweaned bison calves and of other intestinal parasites in adult bison on 98 farms in Manitoba and Saskatchewan. Calf samples were pooled (maximum 5 samples per pool) by farm and positive pools were examined to determine individual T. vitulorum counts. Toxocara vitulorum eggs were found on 4 farms in Manitoba and none in Saskatchewan. Apparent herd-level prevalence estimates were 12% [95% confidence interval (95% CI): 3.4% to 28.2%] and 0% (95% CI: 0% to 5.7%) respectively. Samples from adult bison contained eggs/oocysts from trichostrongyle species, Eimeria sp., Monieza sp., Capillaria sp., Nematodirus sp. and Trichuris sp. in 100%, 95%, 72%, 13%, 13%, and 5% of herds, respectively. Strongyloides sp. were not found in any herd. Further studies are needed to assess parasite distribution patterns in bison and to evaluate the risk that T. vitulorum may pose to bison, cattle, and wildlife.

Une enquête pour détecterToxocara vitulorumet d'autres parasites gastro-intestinaux dans des troupeaux de bisons(Bison bison)du Manitoba et de la Saskatchewan. Une enquête sur la numération des œufs à l'aide d'échantillons fécaux environnementaux obtenus au printemps ou au début de l'été a été réalisée afin d'estimer la prévalence apparente de Toxocara vitulorum chez des veaux de bisons non sevrés et d'autres parasites intestinaux chez les bisons adultes dans 98 fermes du Manitoba et de la Saskatchewan. Les échantillons des veaux ont été regroupés (maximum de 5 échantillons par groupe) par ferme et les groupes positifs ont été examinés afin de déterminer les numérations individuelles de T. vitulorum. Des œufs de Toxocara vitulorum ont été trouvés dans 4 fermes au Manitoba et dans aucune ferme en Saskatchewan. Les estimations de prévalence apparentes au niveau du troupeau étaient de 12 % (intervalle de confiance de 95 % [IC de 95 %] : de 3,4 % à 28,2 %) et 0 % (IC de 95 % : de 0 % à 5,7 %) respectivement. Les échantillons des bisons adultes contenaient des œufs/ookystes d'espèces de trichostrongyles, Eimeria sp., Monieza sp., Capillaria sp., Nematodirus sp. et Trichuris sp. dans 100 %, 95 %, 72 %, 13 %, 13 % et 5 % des troupeaux, respectivement. Strongyloides sp. n'a pas été trouvé dans aucun troupeau. De nouvelles études sont requises pour évaluer les tendances de distribution des parasites chez les bisons et le risque que T. vitulorum puisse poser pour les bisons, le bétail et la faune.(Traduit par Isabelle Vallières).